Topical pimecrolimus: a novel therapeutic option for Netherton syndrome.
Oji
V
V
Beljan
G
G
Beier
K
K
Traupe
H
H
Luger
T A
TA
D002648:Child; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D016113:Ichthyosiform Erythroderma, Congenital / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D013577:Syndrome; D016559:Tacrolimus / Q000031:analogs & derivatives* / Q000627:therapeutic use
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus